These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7577632)

  • 1. Evidence for the aetiological role of blood-borne virus infections in causing reduced lectin-induced T-cell proliferation in haemophilic boys.
    Evans JA; Pasi KJ; Hill FG
    Br J Haematol; 1995 Sep; 91(1):197-202. PubMed ID: 7577632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of changes in monocyte antigen presentation and cytokine production in haemophilic boys with treatment and blood-borne virus infection.
    Pasi KJ; Evans JA; Wadhwa M; Thorpe R; Hill FG
    Br J Haematol; 1995 Sep; 91(1):191-6. PubMed ID: 7577631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological effects of intermediate purity clotting factor concentrates: failure to affect lymphocyte activation in vivo.
    Higgins JA; Giangrande PL; Kernoff PB; Goodall AH
    Br J Haematol; 1993 Feb; 83(2):296-305. PubMed ID: 8457478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y).
    Evans JA; Pasi KJ; Williams MD; Hill FG
    Br J Haematol; 1991 Nov; 79(3):457-61. PubMed ID: 1751373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intermediate-purity factor VIII (FVIII) concentrate on lymphocyte proliferation and apoptosis: transforming growth factor-beta is a significant immunomodulatory component of FVIII.
    Hodge G; Han P
    Br J Haematol; 2001 Nov; 115(2):376-81. PubMed ID: 11703339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive study of immunological abnormalities in Korean hemophiliacs.
    Kim KY; Yang CH; Kang SH; Kim DS
    Yonsei Med J; 1989; 30(2):180-5. PubMed ID: 2508331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.
    Seremetis SV; Aledort LM; Bergman GE; Bona R; Bray G; Brettler D; Eyster ME; Kessler C; Lau TS; Lusher J
    Lancet; 1993 Sep; 342(8873):700-3. PubMed ID: 8103820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of HIV-infected haemophilic boys and the prognostic significance of immune and haematological abnormalities.
    Williams MD; al-Rubei K; Hill FG
    Thromb Haemost; 1988 Aug; 60(1):97-101. PubMed ID: 3263713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
    Froebel KS; Madhok R; Forbes CD; Lennie SE; Lowe GD; Sturrock RD
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1091-3. PubMed ID: 6226334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients.
    Brettler DB; Alter HJ; Dienstag JL; Forsberg AD; Levine PH
    Blood; 1990 Jul; 76(1):254-6. PubMed ID: 2114186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity.
    Vianello F; Tison T; Tagariello G; Zerbinati P; Zanon E; Scarano L; Girolami A
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):393-7. PubMed ID: 10493222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
    Smid WM; van der Meer J; Smit JW; Halie MR
    Thromb Haemost; 1993 Apr; 69(4):306-10. PubMed ID: 8388579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV, HBV and HCV seropositivity in hemophiliacs.
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):339-44. PubMed ID: 1726973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
    Lorenzo JI; Molina R; Aznar JA
    Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in immune response to hepatitis B in boys with haemophilia.
    Williams MD; Boxall EH; Hill FG
    J Med Virol; 1988 Jul; 25(3):317-27. PubMed ID: 3139829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV seroconversion in haemophilic boys receiving heat-treated factor VIII concentrate.
    Williams MD; Skidmore SJ; Hill FG
    Vox Sang; 1990; 58(2):135-6. PubMed ID: 2111060
    [No Abstract]   [Full Text] [Related]  

  • 18. PCR analysis of HIV-1 sequences and differential immunological features in seronegative and seropositive haemophiliacs.
    Chelucci C; Hassan HJ; Gringeri A; Macioce G; Mariani G; Santagostino E; Testa U; Vulcano F; Mannucci PM; Peschle C
    Br J Haematol; 1992 Aug; 81(4):558-67. PubMed ID: 1390244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy.
    Cuthbert RJ; Ludlam CA; Steel CM; Beatson D; Peutherer JF
    Br J Haematol; 1992 Mar; 80(3):364-9. PubMed ID: 1581216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolytic activity against mycobacterial antigens: differences between haemophiliacs with and without HIV infection.
    Pasi KJ; Evans JA; Forte M; Kumararatne DS; Hill FG
    Haemophilia; 1995 Jul; 1(3):178-83. PubMed ID: 27214536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.